Self-experimentation reports: Thousands of individuals using peptides for injuries sharing experiences online (Reddit, forums, social media)
To date, almost all high-quality pediatric clinical trials have been relatively brief (typically 12 years) ( Even though clinical studies show significant weight loss with GLP-1 RAs, and their use in youth has surged, access and application remain uneven
These peptides are popular with athletes and anyone looking to build lean muscle
A 72-week trial carried out on Wegovy found that patients using the 7.2 mg maintenance dose achieved, on average, a change in body weight of 21% compared to 2.4% in the placebo group
Some patients report ongoing symptoms such as persistent nausea, vomiting, abdominal pain, and delayed gastric emptying that do not resolve after discontinuation